New ResearchFull Access
Published Online:16 Apr 2015https://doi.org/10.1176/appi.ajp.2015.14101275
- Cited by
- 14 June 2024 | International Clinical Psychopharmacology, Vol. 29
- 12 June 2024 | Expert Review of Neurotherapeutics, Vol. 29
- 29 January 2024 | Healthcare, Vol. 12, No. 3
- Schizophrenia Research, Vol. 261
- 9 November 2023 | The Journal of Clinical Pharmacology, Vol. 63, No. S2
- 3 July 2023 | Journal of Psychopharmacology, Vol. 37, No. 10
- Current Alzheimer Research, Vol. 20, No. 10
- 31 July 2023 | Psychological Medicine, Vol. 83
- 13 April 2023 | Pharmaceutical Medicine, Vol. 37, No. 3
- 25 February 2023 | Brain Sciences, Vol. 13, No. 3
- 16 March 2023 | Biomedicines, Vol. 11, No. 3
- 4 January 2023 | Biomedicines, Vol. 11, No. 1
- 22 July 2022 | International Clinical Psychopharmacology, Vol. 38, No. 1
- Psychiatry Research Case Reports, Vol. 1, No. 2
- 29 September 2022 | Psikhiatriya, Vol. 20, No. 3
- 29 July 2022 | Advances in Therapy, Vol. 39, No. 9
- Tremor and Other Hyperkinetic Movements, Vol. 12, No. 1
- 8 February 2022 | Schizophrenia Bulletin, Vol. 48, No. 3
- Neuroscience & Biobehavioral Reviews, Vol. 135
- 1 August 2022 | Neuropsychiatric Disease and Treatment, Vol. Volume 18
- Neuroscience & Biobehavioral Reviews, Vol. 132
- 21 August 2021 | Human Psychopharmacology: Clinical and Experimental, Vol. 37, No. 1
- 26 August 2021 | The Journal of Clinical Pharmacology, Vol. 62, No. 1
- 26 August 2021 | The Journal of Clinical Pharmacology, Vol. 62, No. 1
- World Journal of Psychiatry, Vol. 11, No. 12
- 2 December 2021
- 29 November 2021 | Current Psychiatry Reports, Vol. 23, No. 12
- 9 November 2021 | Clinical Drug Investigation, Vol. 41, No. 12
- 13 September 2021 | npj Schizophrenia, Vol. 7, No. 1
- Psychiatry Investigation, Vol. 18, No. 11
- 10 August 2021 | Schizophrenia Bulletin, Vol. 47, No. 6
- 10 March 2021 | Journal of Psychopharmacology, Vol. 35, No. 8
- 26 January 2021 | Human Psychopharmacology: Clinical and Experimental, Vol. 36, No. 4
- 9 March 2021 | Xenobiotica, Vol. 51, No. 5
- 16 November 2020 | European Journal of Clinical Pharmacology, Vol. 77, No. 5
- 1 May 2021 | Schizophrenia Bulletin Open, Vol. 2, No. 1
- Harvard Review of Psychiatry, Vol. 29, No. 1
- 11 November 2020 | Journal of Clinical Psychopharmacology, Vol. 41, No. 1
- 16 May 2020 | Schizophrenia Bulletin, Vol. 46, No. 6
- 1 October 2020 | Psychiatry and Clinical Neurosciences, Vol. 74, No. 12
- Current Molecular Pharmacology, Vol. 13, No. 4
- European Neuropsychopharmacology, Vol. 40
- 21 July 2020 | Expert Opinion on Drug Safety, Vol. 19, No. 8
- Schizophrenia Research, Vol. 222
- 10 July 2020 | Journal of Psychopharmacology, Vol. 34, No. 8
- 3 July 2020 | Neurodegenerative Disease Management, Vol. 10, No. 4
- Psychiatry Research: Neuroimaging, Vol. 301
- 14 February 2020 | Acta Neuropsychiatrica, Vol. 32, No. 3
- 20 May 2020 | Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Vol. 40, No. 6
- 30 January 2020 | Psychopharmacology, Vol. 237, No. 5
- 3 April 2020 | CNS Drugs, Vol. 34, No. 5
- International Clinical Psychopharmacology, Vol. 35, No. 3
- Stefan Leucht,
M.D. , - Alessio Crippa,
Ph.D. , - Spyridon Siafis,
M.D. , - Maxine X. Patel,
M.D. , - Nicola Orsini,
Ph.D. , - John M. Davis,
M.D.
16 December 2019 | American Journal of Psychiatry, Vol. 177, No. 4- Stefan Leucht,
- 12 March 2020 | Expert Opinion on Drug Safety, Vol. 19, No. 3
- International Clinical Psychopharmacology, Vol. 35, No. 2
- 1 December 2020 | Drug Design, Development and Therapy, Vol. Volume 14
- 1 October 2020 | Neuropsychiatric Disease and Treatment, Vol. Volume 16
- 5 September 2019 | Neuropsychopharmacology Reports, Vol. 39, No. 4
- 31 October 2019 | Journal of Clinical Psychopharmacology, Vol. 39, No. 6
- 25 October 2019 | Journal of Clinical Psychopharmacology, Vol. 39, No. 6
- 27 June 2019 | Clinical Drug Investigation, Vol. 39, No. 10
- 7 May 2019 | CNS Drugs, Vol. 33, No. 6
- 27 July 2018 | Current Medical Research and Opinion, Vol. 34, No. 12
- 19 June 2018 | Clinical Pharmacokinetics, Vol. 57, No. 12
- 30 December 2018 | Therapeutic Innovation & Regulatory Science, Vol. 52, No. 5
- 2 July 2018 | Psychiatry and Clinical Neurosciences, Vol. 72, No. 9
- 1 June 2018 | Clinical Drug Investigation, Vol. 38, No. 8
- Journal of Comparative Effectiveness Research, Vol. 7, No. 8
- 26 April 2018 | Psychiatry and Clinical Neurosciences, Vol. 72, No. 6
- 10 October 2017 | Australasian Psychiatry, Vol. 26, No. 1
- 20 November 2017 | Statistics in Medicine, Vol. 36, No. 28
- Clinical Mass Spectrometry, Vol. 6
- Mental Health Clinician, Vol. 7, No. 5
- European Neuropsychopharmacology, Vol. 27, No. 4
- 4 March 2017 | Cochrane Database of Systematic Reviews, Vol. 313
- 26 January 2017 | World Psychiatry, Vol. 16, No. 1
- Journal of Clinical Psychopharmacology, Vol. 37, No. 1
- 17 October 2016 | Therapeutic Advances in Psychopharmacology, Vol. 7, No. 1
- 19 December 2016 | Scientific Reports, Vol. 6, No. 1
- International Clinical Psychopharmacology, Vol. 31, No. 6
- Schizophrenia Research, Vol. 174, No. 1-3
- Schizophrenia Research, Vol. 174, No. 1-3
- 3 December 2015 | Therapeutic Advances in Psychopharmacology, Vol. 6, No. 1
- 20 January 2016 | Expert Review of Neurotherapeutics, Vol. 16, No. 2
- 21 December 2015 | Organic Process Research & Development, Vol. 20, No. 1
- Donald C. Goff,
M.D.
1 September 2015 | American Journal of Psychiatry, Vol. 172, No. 9- Donald C. Goff,
Metrics
The authors thank the investigators at the study sites and the subjects who participated in this study.
History
Received 15 October 2014
Revised 23 December 2014
Accepted 16 January 2015
Published online 16 April 2015
Published in print 1 September 2015
![Loading](/specs/libraries/ui-core/releasedAssets/images/spinner-6fdf6f7f6e2cdc0643c07483defc3379.gif)